Similar articles for PMID: 35086897

Year	Number of Results
2002	2
2006	2
2007	1
2008	2
2009	1
2010	2
2011	4
2012	3
2013	1
2014	4
2015	8
2016	8
2017	11
2018	14
2019	18
2020	16
2021	17
2022	16
2023	9
2024	0

1

Molecular Signature of ¹⁸F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.

Alberge JB, Kraeber-Bodéré F, Jamet B, Touzeau C, Caillon H, Wuilleme S, Béné MC, Kampfenkel T, Sonneveld P, van Duin M, Avet-Loiseau H, Corre J, Magrangeas F, Carlier T, Bodet-Milin C, Chérel M, Moreau P, Minvielle S, Bailly C. Alberge JB, et al. J Nucl Med. 2022 Jul;63(7):1008-1013. doi: 10.2967/jnumed.121.262884. Epub 2022 Jan 27. J Nucl Med. 2022. PMID: 35086897 Free PMC article.

2

Role of ¹⁸F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, San-Miguel J, Kumar SK, Richardson PG, Mikhael JR, da Costa FL, Dimopoulos MA, Zingaretti C, Abildgaard N, Goldschmidt H, Orlowski RZ, Chng WJ, Einsele H, Lonial S, Barlogie B, Anderson KC, Rajkumar SV, Durie BGM, Zamagni E. Cavo M, et al. Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4. Lancet Oncol. 2017. PMID: 28368259 Review.

3

Prognostic value of [¹⁸F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

Stolzenburg A, Lückerath K, Samnick S, Speer M, Kneer K, Schmid JS, Grigoleit GU, Hofmann S, Beer AJ, Bunjes D, Knop S, Buck AK, Einsele H, Lapa C. Stolzenburg A, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1694-1704. doi: 10.1007/s00259-018-3997-0. Epub 2018 Apr 2. Eur J Nucl Med Mol Imaging. 2018. PMID: 29610955

4

Comparison of [¹⁸F]fluciclovine and [¹⁸F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.

Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME. Stokke C, et al. Mol Imaging Biol. 2022 Oct;24(5):842-851. doi: 10.1007/s11307-022-01734-0. Epub 2022 May 2. Mol Imaging Biol. 2022. PMID: 35501622 Free PMC article.

5

Prognostic value of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis.

Han S, Woo S, Kim YI, Yoon DH, Ryu JS. Han S, et al. Eur Radiol. 2021 Jan;31(1):152-162. doi: 10.1007/s00330-020-07177-x. Epub 2020 Aug 18. Eur Radiol. 2021. PMID: 32809165

6

¹¹C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to ¹⁸F-FDG PET/CT and Prognostic Value.

Morales-Lozano MI, Rodriguez-Otero P, Sancho L, Nuñez-Cordoba JM, Prieto E, Marcos-Jubilar M, Rosales JJ, Alfonso A, Guillen EF, San-Miguel J, Garcia-Velloso MJ. Morales-Lozano MI, et al. Int J Mol Sci. 2022 Aug 31;23(17):9895. doi: 10.3390/ijms23179895. Int J Mol Sci. 2022. PMID: 36077292 Free PMC article.

7

Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.

Jamet B, Zamagni E, Nanni C, Bailly C, Carlier T, Touzeau C, Michaud AV, Moreau P, Bodet-Milin C, Kraeber-Bodere F. Jamet B, et al. Int J Mol Sci. 2020 Jul 29;21(15):5406. doi: 10.3390/ijms21155406. Int J Mol Sci. 2020. PMID: 32751375 Free PMC article. Review.

8

Prognostic Value of Baseline ¹⁸F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study.

Moon SH, Choi WH, Yoo IR, Lee SJ, Paeng JC, Jeong SY, Lee SW, Kim K, Choi JY. Moon SH, et al. Korean J Radiol. 2018 May-Jun;19(3):481-488. doi: 10.3348/kjr.2018.19.3.481. Epub 2018 Apr 6. Korean J Radiol. 2018. PMID: 29713226 Free PMC article.

9

11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.

Chen M, Zhu W, Du J, Yang C, Han B, Zhou D, Huo L, Zhuang J. Chen M, et al. Sci Rep. 2021 Nov 12;11(1):22188. doi: 10.1038/s41598-021-01740-2. Sci Rep. 2021. PMID: 34773054 Free PMC article.

10

Standardization of ¹⁸F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma.

Zamagni E, Nanni C, Dozza L, Carlier T, Bailly C, Tacchetti P, Versari A, Chauvie S, Gallamini A, Gamberi B, Caillot D, Patriarca F, Macro M, Boccadoro M, Garderet L, Barbato S, Fanti S, Perrot A, Gay F, Sonneveld P, Karlin L, Cavo M, Bodet-Milin C, Moreau P, Kraeber-Bodéré F. Zamagni E, et al. J Clin Oncol. 2021 Jan 10;39(2):116-125. doi: 10.1200/JCO.20.00386. Epub 2020 Nov 5. J Clin Oncol. 2021. PMID: 33151787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year